VCA Inc  

(Public, NASDAQ:WOOF)   Watch this stock  
Find more results for WOOF
54.40
+0.24 (0.45%)
After Hours: 54.00 -0.40 (-0.74%)
Jun 30, 6:44PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 54.34 - 54.89
52 week 34.58 - 56.01
Open 54.52
Vol / Avg. 489,033.00/491,591.00
Mkt cap 4.45B
P/E 33.64
Div/yield     -
EPS 1.62
Shares 82.16M
Beta 1.06
Inst. own 94%
Jul 22, 2015
Q2 2015 VCA Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 1, 2015
VCA Inc at Jefferies Global Healthcare Conference
May 12, 2015
VCA Inc at Bank of America Merrill Lynch Health Care Conference
Apr 29, 2015
Q1 2015 VCA Inc Earnings Call - Webcast
Apr 29, 2015
Q1 2015 VCA Inc Earnings Release
Apr 16, 2015
VCA Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 7.92% 7.33%
Operating margin 13.84% 12.80%
EBITD margin - 18.38%
Return on average assets 6.81% 6.16%
Return on average equity 12.88% 10.80%
Employees 11,500 -
CDP Score - -

Address

12401 W Olympic Blvd
LOS ANGELES, CA 90064-1022
United States - Map
+1-310-5716500 (Phone)
+1-310-5716700 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company's animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company's communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company's network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Officers and directors

Robert L. Antin Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tomas W. Fuller Chief Financial Officer, Vice President, Principal Accounting Officer, Secretary
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Josh Drake President - Antech Diagnostics
Age: 47
Bio & Compensation  - Reuters
Arthur J. Antin Chief Operating Officer, Senior Vice President
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Neil Tauber Senior Vice President - Development
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John M. Baumer Independent Director
Age: 47
Bio & Compensation  - Reuters
John B. Chickering Jr. Independent Director
Age: 65
Bio & Compensation  - Reuters
John A. Heil Independent Director
Age: 62
Bio & Compensation  - Reuters
Frank Reddick Independent Director
Age: 62
Bio & Compensation  - Reuters